Metabolic Rejuvenation in Type 2 Diabetes: A Network Biology Perspective on Functional Restoration and Disease Modification

Type 2 diabetes (T2D) is increasingly recognized as a systemic network disorder in which impaired communication among endocrine, neural, immune, and microbial systems drives metabolic dysfunction and accelerates biological aging. Extending DeFronzo’s “Ominous Octet,” contemporary advances in immunometabolism, mitochondrial biology, circadian physiology, and incretin signaling demonstrate that metabolic homeostasis depends on the structural and functional integrity of dynamic inter-organ networks. Their progressive disruption contributes not only to classical insulin resistance and β-cell failure, but also to chronic low-grade inflammation (inflammaging), mitochondrial decay, autonomic dysregulation, and epigenetic age acceleration. Crucially, modern disease-modifying interventions—including multi-incretin receptor agonists, SGLT2 inhibitors, metabolic/bariatric surgery, and circadian-aligned lifestyle programs—produce pleiotropic benefits that extend far beyond simple glycemic control. These convergent effects suggest partial restoration of impaired metabolic networks rather than isolated correction of glucose abnormalities. In this review, we propose “Metabolic Rejuvenation” as a novel, unifying operational framework describing the systemic restoration of metabolic network integrity, physiological resilience, and biological adaptability. Mechanistically, we discuss how reactive aldehyde-driven glycative stress operates within a multifactorial cascade—together with chronic inflammation and organelle dysfunction—to drive metabolic network collapse and accelerate biological aging. Finally, we outline a multidimensional assessment framework spanning five measurable domains (Inflammatory, Energetic & Mitochondrial, Autonomic & Neuroendocrine, Clinical & Metabolic, and Digital & Behavioral) to quantify disease modification, β-cell preservation, and diabetes remission potential toward healthy metabolic longevity.

Authors

Institutions

Publication Details

Journal
Diabetology
Published
2026-10-09
DOI
https://doi.org/10.3390/diabetology7100195
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metabolic Rejuvenation in Type 2 Diabetes: A Network Biology Perspective on Functional Restoration and Disease Modification

Teruyoshi Tanaka, Yoshikazu Yonei, Hiroshi Yamamoto
Diabetology
Diabetes Treatment and Management
article

Metabolic Rejuvenation in Type 2 Diabetes: A Network Biology Perspective on Functional Restoration and Disease Modification

Teruyoshi Tanaka, Yoshikazu Yonei, Hiroshi Yamamoto
article en

Abstract

Type 2 diabetes (T2D) is increasingly recognized as a systemic network disorder in which impaired communication among endocrine, neural, immune, and microbial systems drives metabolic dysfunction and accelerates biological aging. Extending DeFronzo’s “Ominous Octet,” contemporary advances in immunometabolism, mitochondrial biology, circadian physiology, and incretin signaling demonstrate that metabolic homeostasis depends on the structural and functional integrity of dynamic inter-organ networks. Their progressive disruption contributes not only to classical insulin resistance and β-cell failure, but also to chronic low-grade inflammation (inflammaging), mitochondrial decay, autonomic dysregulation, and epigenetic age acceleration. Crucially, modern disease-modifying interventions—including multi-incretin receptor agonists, SGLT2 inhibitors, metabolic/bariatric surgery, and circadian-aligned lifestyle programs—produce pleiotropic benefits that extend far beyond simple glycemic control. These convergent effects suggest partial restoration of impaired metabolic networks rather than isolated correction of glucose abnormalities. In this review, we propose “Metabolic Rejuvenation” as a novel, unifying operational framework describing the systemic restoration of metabolic network integrity, physiological resilience, and biological adaptability. Mechanistically, we discuss how reactive aldehyde-driven glycative stress operates within a multifactorial cascade—together with chronic inflammation and organelle dysfunction—to drive metabolic network collapse and accelerate biological aging. Finally, we outline a multidimensional assessment framework spanning five measurable domains (Inflammatory, Energetic & Mitochondrial, Autonomic & Neuroendocrine, Clinical & Metabolic, and Digital & Behavioral) to quantify disease modification, β-cell preservation, and diabetes remission potential toward healthy metabolic longevity.

DiabetologyVol. 7(10)
Doshisha University (JP), Shiga Medical Center (JP), Kindai University (JP)
Openalex Percentile: Top 11%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.